| __timestamp | Taro Pharmaceutical Industries Ltd. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 179279000 | 570979 |
| Thursday, January 1, 2015 | 186359000 | 2185000 |
| Friday, January 1, 2016 | 171785000 | 4554000 |
| Sunday, January 1, 2017 | 208136000 | 3605000 |
| Monday, January 1, 2018 | 198405000 | 5527000 |
| Tuesday, January 1, 2019 | 224169000 | 5234000 |
| Wednesday, January 1, 2020 | 245044000 | 6126000 |
| Friday, January 1, 2021 | 252314000 | 6784000 |
| Saturday, January 1, 2022 | 268225000 | 7592000 |
| Sunday, January 1, 2023 | 304629000 | 11450000 |
| Monday, January 1, 2024 | 324203000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, understanding cost structures is crucial. Taro Pharmaceutical Industries Ltd. and Travere Therapeutics, Inc. offer a fascinating comparison. Over the past decade, Taro's cost of revenue has shown a steady upward trend, increasing by approximately 81% from 2014 to 2023. This growth reflects Taro's expanding operations and market presence. In contrast, Travere Therapeutics, Inc. has experienced a more modest increase, with costs rising nearly 20 times from 2014 to 2023, albeit from a much smaller base. This disparity highlights the different scales and strategies of these companies. Notably, data for 2024 is incomplete, suggesting potential shifts in the coming year. As the pharmaceutical industry evolves, monitoring these financial metrics will be key to understanding each company's strategic direction and market positioning.
Cost Insights: Breaking Down Eli Lilly and Company and Travere Therapeutics, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue: Key Insights for AstraZeneca PLC and Travere Therapeutics, Inc.
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.'s Expenses
Halozyme Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Grifols, S.A. vs Travere Therapeutics, Inc.
Cost Insights: Breaking Down Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.'s Expenses
Cost of Revenue Comparison: Alkermes plc vs Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Vericel Corporation and Taro Pharmaceutical Industries Ltd.
Comparing Cost of Revenue Efficiency: Ligand Pharmaceuticals Incorporated vs Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?